Indexing
All Issues
Submission
Author Guidelines
Reviewers
Editorial Members
Publication Fee
Vol.2 , No. 1, Publication Date: Mar. 1, 2016, Page: 1-8
 a primary metabolite with reported psychotropic effects. Therefore, the presence of THC makes controversial the use of <i>Cannabis</i> to treat diseases by which their uses and applications were limited. The question then is: is it possible to use the extracts from <i>Cannabis</i> to treat the diseases related with it use in folk medicine? More recently, the synergistic contributions of bioactive constituents have been scientifically demonstrated. We reviewed the literature concerning medical cannabis and its secondary metabolites, including fraction and total extracts. Scientific evidence shows that secondary metabolites in cannabis may enhance the positive effects of THC a primary metabolite. Other chemical components (cannabinoid and non-cannabinoid) in cannabis or its extracts may reduce THC-induced anxiety, cholinergic deficits, and immunosuppression; which could increase its therapeutic potential. Particular attention will be placed on non-cannabinoid compounds interactions that could produce synergy with respect to treatment of pain, inflammation, epilepsy, fungal and bacterial infections. The evidence accessible herein pointed out for the possible synergism that might occur involving the main phytocompounds with each other or with other minor components.&picture=http://www.aascit.org/aascit/decorators/img/journal/890.jpg)
| [1] | Maria Rosana Ramirez, CITER-The National Scientific and Technical Research Council (CONICET), Argentine Government, Agency, Argentina. |
A central tenet underlying the use of plant preparations is that herbs contain many bioactive compounds. Cannabis contains tetrahydrocannabinols (THC) a primary metabolite with reported psychotropic effects. Therefore, the presence of THC makes controversial the use of Cannabis to treat diseases by which their uses and applications were limited. The question then is: is it possible to use the extracts from Cannabis to treat the diseases related with it use in folk medicine? More recently, the synergistic contributions of bioactive constituents have been scientifically demonstrated. We reviewed the literature concerning medical cannabis and its secondary metabolites, including fraction and total extracts. Scientific evidence shows that secondary metabolites in cannabis may enhance the positive effects of THC a primary metabolite. Other chemical components (cannabinoid and non-cannabinoid) in cannabis or its extracts may reduce THC-induced anxiety, cholinergic deficits, and immunosuppression; which could increase its therapeutic potential. Particular attention will be placed on non-cannabinoid compounds interactions that could produce synergy with respect to treatment of pain, inflammation, epilepsy, fungal and bacterial infections. The evidence accessible herein pointed out for the possible synergism that might occur involving the main phytocompounds with each other or with other minor components.
Keywords
Non-cannabinoids Compounds, Cannabis Extracts, Bioactivity
Reference
| [01] | Núñez-Sellés AJ, Delgado-Hernández R, Garrido-Garrido G, García-Rivera D, Guevara-García M, Pardo-Andreu GL. The paradox of natural products as pharmaceuticals: Experimental evidences of a mango stem bark extract. Pharmacol Res 2007, 55: 351-358. |
| [02] | Dreher M. Crack heads and roots daughters: the therapeutic use of cannabis in Jamaica. J Cannabis Therap 2002, 2: 121-133. |
| [03] | Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers 2007, 4: 1614-1648. |
| [04] | Gaoni Y & Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964, 86: 1646-1647. |
| [05] | Turner CE, Elsohly MA, Boeren EG. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 1980, 43: 169-304. |
| [06] | Sparacino CM, Hyldburg PA, Hughes TJ. Chemical and biological analysis of marijuana smoke condensate. NIDA Res Monogr 1990, 99: 121-140. |
| [07] | Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988, 34: 605-613. |
| [08] | Barros DM, Carlis V, Maidana M, Silva ES, Baisch AL, Ramirez MR, Izquierdo I. Interactions between anandamide-induced anterograde amnesia and post-training memory modulatory systems. Brain Res 2004, 30, 1016 (1): 66-71. |
| [09] | Musshoff F & Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit 2006, 28: 155-163. |
| [10] | Happyana N, Agnolet S, Muntendam R, Van Dam A, Schneider B, et al. Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. Phytochemistry 2013, 87: 51-59. |
| [11] | Gill EW & Paton WDM, Pertwee RG. Preliminary experiments on the chemistry and pharmacology of Cannabis. Nature 1970, 228: 134-6. |
| [12] | Mechoulam R, Ben-Zvi Z, Shani A, Zemler H, Levy S. 1972. Cannabinoids and Cannabis activity In: Cannabis and its derivatives. Paton WDM, Crown J, eds. London: Oxford University Press, pp. 1-13. |
| [13] | McPartland JM & Pruitt PP. Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana. Altern Therap 1999, 5: 57-62. |
| [14] | Ethan B Russo. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011, 163, 1344-1364. |
| [15] | Ahmad UK, Muniandy Y, Hassan MS. Physical Analysis and Chemical Profiling of Illicit Herbal Cannabis using Multivariate Analysis. MJOFS 2014, 5: 26-34. |
| [16] | Elzinga S, Fischedick J, Podkolinski R and Raber JC. Cannabinoids and Terpenes as Chemotaxonomic Markers in Cannabis. Nat Prod Chem Res 2015, 3: 4. |
| [17] | Thompson GR, Rosenkrantz H, Schaeppi UH, Braude MC. Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys. Toxicol Appl Pharmacol 1973, 25: 363-73. |
| [18] | Pate D. 1994. Chemical ecology of cannabis. J Internat Hemp Assoc 1994, 2: 32-37. |
| [19] | Bornheim LM, Kim KY, Li J, Perotti BY, Benet LZ. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab Dispos 1995, 23: 825-31. |
| [20] | ElSohly M. Chemical constituents of Cannabis, in Cannabis and cannabinoids-Pharmacology, Toxicology and Therapeutic Potential (Grotenhermen, F. and Russo, E., eds.), Haworth Press, New York, 2002, pp. 27–36. |
| [21] | Agrawal AK, Kumar P, Gulati A, Seth PK. Cannabis-induced neurotoxicity in mice: effects on cholinergic (muscarinic) receptors and blood brain barrier permeability. Res Commun Subst Abuse 1989, 10: 155-68. |
| [22] | Russo E. Hemp for headache: an in-depth historical and scientific review of cannabis in migraine treatment. J Cann Ther 2001, 1, 21–92. |
| [23] | De Oliveira AC, Ribeiro-Pinto LF, Paumgartten JR. In vitro inhibition of CYP 2B1 monooxygenase by beta-myrcene and other monoterpenoid compounds. Toxicol Lett 1997, 92: 39-46. |
| [24] | Evans AT, Formukong EA, Evans FJ. Actions of cannabis constituents on enzymes of arachidonate metabolism: anti-inflammatory potential. Bioch Pharmacol 1987, 36: 2035-7. |
| [25] | Burstein S, Varanelli C, Slade LT. Prostaglandins and Cannabis–III. Inhibition of biosynthesis by essential oil components of marihuana. Biochem Pharmacol 1975, 24: 1053-4. |
| [26] | Burstein S, Taylor P, El-Feraly FS, Turner C. Prostaglandins and Cannabis– V. Identification of p-vinylphenol as a potent inhibitor of prostaglandin synthesis. Biochem Pharmacol 1976, 25: 2003-2004. |
| [27] | Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M et al. Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J Nat Prod 2008, 71: 1427-1430. |
| [28] | Arruda DC, D’Alexandri FL, Katzin AM, Uliana SR. Antileishmanial activity of the terpene nerolidol. Antimicrob Agents Chemother 2005, 49: 1679-1687. |
| [29] | Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ et al. Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 2008, 105: 9099-9104. |
| [30] | Nigam MC, Handa KL, Nigam IC, Levi L. Essential oils and their constituents. XXIX. The essential oil of marihuana: composition of the genuine Indian Cannabis sativa L. Canad J Che 1965, 43: 3372-3376. |
| [31] | Novak J, Zitterl-Eglseer K, Deans SG, Franz CM. Essential oils of different cultivars of Cannabis sativa L. and their antimicrobial activity. Flavour Fragr J 2001, 16: 259-262. |
| [32] | Onawunmi GO, Yisak WA, Ogunlana EO. Antibacterial constituents in the essential oil of Cymbopogon citratus (DC.) Stapf. J Ethnopharmacol 1984, 12: 279-86. |
| [33] | Ross SA & ElSohly MA. The volatile oil composition of fresh and air-dried buds of Cannabis sativa. J Nat Prod 1996, 59: 49-51. |
| [34] | Santos FA & Rao VS. Anti-inflammatory and antinociceptive effects of 1, 8-cineole a terpenoid oxide present in many plant essential oils. Phytother Res 2000, 14: 240-4. |
| [35] | Tambe Y, Tsujiuchi H, Honda G, Ikeshiro Y, Tanaka S. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Planta Med 1996, 62: 469-70. |
| [36] | Rao VSN, Menezes AMS, Viana GSB. Effect of myrcene on nociception in mice. J Pharm Pharmacol 1990, 42: 877-8. |
| [37] | Jones CLA. Monoterpenes: Essence of a cancer cure. Nutr Sci News 1999, 4 (4): 190. |
| [38] | Greene-McDowelle DM, Ingber B, Wright MS, Zeringue HJ, Bhatnagar D, Cleveland TE. The effects of selected cotton-leaf volatiles on growth, development and aflatoxin production of Aspergillus parasiticus. Toxicon 1999, 37: 883-93. |
| [39] | Paris RR, Henri E, Paris M. Sur les c-flavonoïdes du Cannabis sativa L. Plantes Médicinales et Phytothérapie 1976, 10: 144-54. |
| [40] | Barrett ML, Scutt AM, Evans FJ. Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia 1986, 42: 452-463. |
| [41] | Barrett ML, Gordon D, Evans FJ. Isolation from Cannabis sativa L. of cannflavin—a novel inhibitor of prostaglandin production. Biochem Pharmacol 1985, 34, 2019-2024. |
| [42] | Fenselau C & Hermann G. Identification of phytosterols in red oil extract of cannabis. J Forens Sci 1972, 17: 309-312. |
| [43] | Burstein SH, Karst M, Schneider U, Zurier RB. Ajulemic acid: A novel cannabinoid produces analgesia without a “high.” Life Sci 2004, 75: 1513-1522. |
| [44] | Vann RE, Cook CD, Martin BR, Jenny L, Wiley JL. Cannabimimetic properties of ajulemic acid. J Pharmacol Exp Ther 2007, 320: 678-686. |
| [45] | Zurier, R. B., R. G. Rossetti, S. H. Burstein, and B. Bidinger. Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid. Biochem Pharmacol 2003, 65 (4): 649-655. |
| [46] | Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care 2004, 21: 95-104. |
| [47] | Kausar W, Muhammad A, Ul-Haq I. Effect of cannabis on intraocular pressure. Pak J Pharmacol 1995, 12: 43-48. |
| [48] | Green K, Symonds CM, Elijah DR, Zalkow LH, Deutsch HM, Bowman KA, Morgan TR. Water soluble marihuana-derived material: Pharmacological actions in rabbit and primate. Curr Eye Res 1981, 1: 599-608. |
| [49] | Cutler MG, Mackintosh JH, Chance MRA. Cannabis resin and sexual behaviour in the laboratory mouse. Psychopharmacologia 1975, 45: 129-131. |
| [50] | Mendelson JH, Ellingboe J, Kuehnle JC, Dixit VP, Lohiya NK. Effects of cannabis extract on the response of accessory sex organs of adult male mice to testosterone. Indian J Physiol Pharmacol 1975, 19: 98-100. |
| [51] | Mello NK. Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J Pharmacol Exp Ther 1978, 207: 611-617. |
| [52] | Varsha Zade, Manisha Wikhe, Dinesh Dabhadkar, Sagar Dawada, Uddhao Patil. Antifertility efficacy of Cannabis sativa leaves on female albino rats. IJSIT, 2013, 2 (2), 107-117 |
| [53] | Kostellow AB, Ziegler D, Kunar J, Fujimoto GI, Morrill GA. Effect of cannabinoids on estrous cycle, ovulation, and reproduction capacity of female A/J mice. Pharmacology 1980, 21: 68-75. |
| [54] | Frischknecht HR, Sieber B, Waser PG. Effects of multiple, chronic and early hashish exposure on mating behavior, nest-building, and gestation in mice. Comp Biochem Physiol 1982, 77: 363-368. |
| [55] | Hembree III, WC, Nahas GG, Zeidenberg P, Huang HFS. Changes in human spermatozoa associated with high dose marihuana smoking. Adv Biosci 1997, 1979: 429-439. |
| [56] | Dixit VP. Effects of Cannabis sativa extract on testicular function of Presbytis entellus. Planta Med 1981, 41: 288-294. |
| [57] | Dixit VP, Sharma VN, Lohiya NK. The effect of chronically administered cannabis extract on the testicular function of mice. Eur J Pharmacol 1974, 26: 111-114. |
| [58] | Formukong EA, Evans AT, Evans FJ. Analgesic and antiinflammatory activity of constituents of Cannabis sativa L. Inflammation (NY) 1988, 12: 361-371. |
| [59] | Dhar ML, Dhar MM, Mehrotra BN, Ray C. Screening of Indian plants for biological activity. Part I. Indian J Exp Biol 1968, 6: 232-247. |
| [60] | Rousinov KS & Athanasova Shopova S. Experimental screening of the anticonvulsive activity of certain plants used in popular medicine in Bulgaria. C R Acad Bulg Sci 1966, 19: 333-336. |
| [61] | Franke C, Trovato AE, Giagnoni G. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 2004, 369: 294-299. |
| [62] | Sofia RD, Vassar HB, Knobloch LC. Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacologia 1975, 40: 285-295. |
| [63] | Segelman AB, Segelman FP, Sofia RD, Star AE. Some pharmacological effects of certain cannabinoid free marijuana extracts. Lloydia 1974, 37: 645A. |
| [64] | Dwivedi C & Harbison RD. Anticonvulsant activities of delta-8- and delta-9-tetrahydrocannabinol and uridine. Toxicol Appl Pharmacol 1975, 31: 452-458. |
| [65] | Feeney DM. Marihuana and epilepsy. Science 1977, 197: 1301. |
| [66] | Hill AJ, Williams CM, Whalley BJ, Stephens GJ. Phytocannabinoids as novel therapeutic agents in CNS disorders Pharmacol Ther 2012, 133: 79-97. |
| [67] | Cilio MR, Thiele EA, Devinsky O. The case for assessing cannabidiol in epilepsy. Epilepsia 2014, 55: 87-90. |
| [68] | Robson PJ. Therapeutic potential of cannabinoid medicines. Drug Test Anal 2014; 6: 24-30. |
| [69] | Maa E & Figi P. The case for medical marijuana in epilepsy. Epilepsia 2014, 55: 783-786. |
| [70] | dos Santos RG, Hallak JEC, Leite JP, Zuardi AW, Crippa JAS. Phytocannabinoids and epilepsy. J Clin Pharm Ther 2015, 40: 135-143. |
| [71] | Kubo M, Matsuda H, Fukui M, Nakai Y. Development studies of cuticle drugs from natural resources. I. Effects of crude drug extracts on hair growth in mice. Yakugaku Zasshi 1988, 108: 971-978. |
| [72] | Singh KV & Pathak RK. Effect of leaves extracts of some higher plants on spore germination of Ustilago maydes and U. nuda. Fitoterapia 1984, 55: 318-320. |
| [73] | Renu. Fungitoxicity of leaf extracts of some higher plants against Rhizoctonia solani Kuehn. Nat Acad Sci Lett 1983, 6: 245-246. |
| [74] | Nene YL, Thapliyal PN, Kumar K. Screening of some plant extracts for antifungal properties. Lab Dev J Sci Tech B 1968, 6: 226-228. |
| [75] | Sato A. Studies on anti-tumor activity of crude drugs. The effects of aqueous extracts of some crude drugs in short-term screening test. Yakugaku Zasshi 1989, 109: 407-423. |
| [76] | Montour JL, Dutz W, Harris LS. Modification of radiation carcinogenesis by marihuana. Cancer 1981, 47: 1279-1285. |
| [77] | Wright PL, Smith SH, Keplinger ML, Calandra JC, Braude MC. Reproductive and teratologic studies with delta 9-tetrahydrocannabinol and crude marijuana extract. Toxicol Appl Pharmacol 1976, 38: 223-235. |
| [78] | Sethi N, Nath D, Singh RK, Srivastava RK. Antifertility and teratogenic activity of Cannabis sativa in rats. Fitoterapia 1991, 62 (1): 69-71. |
| [79] | Cozens DD, Clark R, Palmer AK, Hardy N, Nahas GG, Harvey DJ. The effect of a crude marihuana extract on embryonic and fetal development of the rabbit. Adv Biosci Marihuana Biological Effects 1978, 22: 469-477. |
| [80] | Agnihotri PK, Singh RK, Sethi SN. Fototoxic effects of crude alcoholic Cannabis sativa extract in rats. Fitoterapia 1992, 63: 489-492. |
